Publication & Citation Trends
Most Cited Works
Publications
73 total
Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community Setting OA
Cited by 6
Semantic Scholar
Abstract P6-18-11: Long-term responders to single-agent margetuximab, an Fc-modified anti-HER2 monoclonal antibody, in metastatic HER2+ breast cancer patients with prior anti-HER2 therapy
Cited by 3
Semantic Scholar
Activity of the FGFR1–3 inhibitor infigratinib in patients with upper tract urothelial carcinoma and urothelial carcinoma of the bladder: Latest efficacy findings and comprehensive genomic profiling/cell-free DNA data
Cited by 0
Semantic Scholar
Abstract P6-18-07: Ribociclib + endocrine therapy in patients with hormone receptor-positive, HER2-negative advanced breast cancer presenting with visceral metastases: Subgroup analysis of phase III MONALEESA trials
Cited by 6
Semantic Scholar
Abstract P6-18-15: Ribociclib + endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled safety analysis
Cited by 1
Semantic Scholar
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer PDF
Cited by 850
OpenAlex
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors OA
Cited by 199
Semantic Scholar
Abstract P1-12-04: A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC)
Cited by 1
Semantic Scholar
Abstract P2-16-17: Characterization of response to everolimus (EVE) in BOLERO-2: A phase 3 trial of EVE plus exemestane (EXE) in postmenopausal women with HR+, HER2- advanced breast cancer
Cited by 2
Semantic Scholar
Breast cancer, locally advanced and metastatic OA
Cited by 10
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(25)
HER2/EGFR in Cancer Research
(19)
Lung Cancer Research Studies
(17)
Colorectal Cancer Treatments and Studies
(16)
Lung Cancer Treatments and Mutations
(14)
Frequent Co-Authors
Affiliations
United States Army Medical Command
University of North Carolina at Chapel Hill
University of Maryland, Baltimore
University of South Carolina Upstate
Fox Chase Cancer Center